KansasHB 22182025–2026 Regular SessionHouse

Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

Sponsored By: Sponsor information unavailable

Failed

health and human services

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Stricken from Calendar by Rule 1507

    2/19/2026House
  2. Committee of the Whole - Passed over and retain a place on the calendar

    2/18/2026House
  3. Committee Report recommending bill be passed as amended by Committee on Health and Human Services

    1/28/2026House
  4. Hearing: Tuesday, February 11, 2025, 1:30 PM Room 112-N

    2/11/2025House
  5. Introduced

    2/3/2025House
  6. Referred to Committee on Health and Human Services

    2/3/2025House

Bill Text

  • As Amended by House Committee

  • As introduced

Related Bills

Back to State Legislation